fostemsavir tromethamine · Viiv Hlthcare · NDA 212950
Rukobia
Earliest generic entry, as listed
13 Jul 2029
Blocked by patent: US 8168615.
Listed patents · 2 unexpired
| Patent | Claims | Expires |
|---|---|---|
| US 8168615 | drug product · sets the listed date | 13 Jul 2029 |
| US 7745625 | drug substance | 19 Nov 2027 |
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.
Products covered · 1
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 212950 · 001 · RLD | tablet, extended release, oral | EQ 600MG BASE | 13 Jul 2029 |